Biosimilars could be launching a lot earlier in the UK than the EU thanks to new guidance, improved ...
Read moreFrance's new Social Security Financing Bill (SSFB) will be coming into place no later than July 1st.
Read moreAre we one step closer to an EU Health Technology Assessment body. The EESC publish its positive opi...
Read moreThere is a large opportunity many companies are still yet to seize in this area.
Read moreNICE’s Highly-Specialised Technologies (HST) process is a method for evaluating medicines and trea...
Read moreNICE has set out its plan using four key pillars designed to elicit incremental change within the UK...
Read moreSecuring patient access in specialty products is becoming increasingly challenging due to the comple...
Read moreReal-world evidence (RWE) is increasingly playing an important role in developing product value prop...
Read moreThe highly specialised technologies (HST) process was introduced in 2013 for the purpose of evaluati...
Read more